BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+16.96%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.82B
AUM Growth
+$1.82B
(+25%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
8.16%
Top 10 Holdings %
Top 10 Hldgs %
36.79%
Holding
154
New
14
Increased
82
Reduced
29
Closed
17
Top Buys
| 1 |
Humana
HUM
|
$19.6M |
| 2 |
Evolent Health
EVH
|
$17.1M |
| 3 |
Teladoc Health
TDOC
|
$16.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
$9.97M |
| 5 |
AVDR
Avedro, Inc Common Stock
AVDR
|
$9.2M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$60.4M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$6.49M |
| 3 |
Amgen
AMGN
|
$5.79M |
| 4 |
MacroGenics
MGNX
|
$4.97M |
| 5 |
Insmed
INSM
|
$4.35M |
Sector Composition
| 1 | Healthcare | 91.36% |
| 2 | Industrials | 1.12% |
| 3 | Technology | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cencora
COR
$57.2B
| $19.9M | 1.1% |
250,398
+3,636
| +1% | +$289K |
|
27
Esperion Therapeutics
ESPR
$490M
| $19.9M | 1.09% |
495,547
+43,575
| +10% | +$1.75M |
|
|
FIT
28
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $19.4M | 1.06% |
3,268,934
+50,050
| +2% | +$296K |
|
|
29
Insmed
INSM
$30.3B
| $19.2M | 1.05% |
659,434
-149,712
| -19% | -$4.35M |
|
30
HUTCHMED
HCM
$2.62B
| $18.3M | 1.01% |
598,310
+158,141
| +36% | +$4.84M |
|
|
WMGI
31
DELISTED
Wright Medical Group Inc
WMGI
| $18M | 0.99% |
573,595
-104,519
| -15% | -$3.29M |
|
|
32
Evolent Health
EVH
$1.11B
| $17.7M | 0.97% |
1,408,237
+1,362,967
| +3,011% | +$17.1M |
|
|
ALDR
33
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $17.6M | 0.97% |
1,286,748
+162,935
| +14% | +$2.22M |
|
|
ABMD
34
DELISTED
Abiomed Inc
ABMD
| $17M | 0.93% |
59,389
+20,567
| +53% | +$5.87M |
|
|
GNMK
35
DELISTED
GenMark Diagnostics, Inc
GNMK
| $16.7M | 0.92% |
2,353,067
+353,527
| +18% | +$2.51M |
|
|
PRAH
36
DELISTED
PRA Health Sciences, Inc.
PRAH
| $16.5M | 0.91% |
149,507
+7,207
| +5% | +$795K |
|
37
LivaNova
LIVN
$3.09B
| $16.2M | 0.89% |
166,956
+39,446
| +31% | +$3.84M |
|
38
DexCom
DXCM
$30.9B
| $15.6M | 0.86% |
524,584
+213,352
| +69% | +$6.35M |
|
39
Zimmer Biomet
ZBH
$20.8B
| $14.7M | 0.81% |
118,400
+23,533
| +25% | +$2.92M |
|
|
WBA
40
DELISTED
Walgreens Boots Alliance
WBA
| $14.7M | 0.81% |
231,802
+9,000
| +4% | +$569K |
|
41
QuidelOrtho
QDEL
$1.87B
| $14.6M | 0.81% |
223,580
+98,580
| +79% | +$6.45M |
|
42
Nektar Therapeutics
NKTR
$543M
| $14.4M | 0.8% |
28,668
+11,254
| +65% | +$5.67M |
|
|
AKCA
43
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $14.3M | 0.79% |
504,411
+46,115
| +10% | +$1.31M |
|
|
44
MacroGenics
MGNX
$121M
| $14.2M | 0.78% |
790,305
-276,688
| -26% | -$4.97M |
|
45
CareDx
CDNA
$678M
| $13.6M | 0.75% |
431,568
-104,920
| -20% | -$3.31M |
|
|
ONC
46
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $13.5M | 0.74% |
102,200
+18,600
| +22% | +$2.46M |
|
47
Integra LifeSciences
IART
$1.18B
| $12.4M | 0.68% |
222,350
+76,571
| +53% | +$4.27M |
|
48
Globus Medical
GMED
$7.94B
| $11.8M | 0.65% |
238,510
+85,479
| +56% | +$4.22M |
|
49
Omnicell
OMCL
$1.51B
| $11.6M | 0.64% |
143,839
+35,797
| +33% | +$2.89M |
|
50
Thermo Fisher Scientific
TMO
$183B
| $10.6M | 0.59% |
38,858
+2,166
| +6% | +$593K |
|